Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1989 Jun;27(6):837–842. doi: 10.1111/j.1365-2125.1989.tb03447.x

Systemic beta-adrenoceptor responses to salbutamol given by metered-dose inhaler alone and with pear shaped spacer attachment: comparison of electrocardiographic, hypokalaemic and haemodynamic effects.

B J Lipworth 1, D G McDevitt 1, A D Struthers 1
PMCID: PMC1379812  PMID: 2547409

Abstract

1. Seven normal subjects were given cumulative doubling doses of inhaled salbutamol either by metered-dose inhaler (MDI) alone, or in conjunction with a pear shaped spacer attachment (PSS). Dose increments were made every 20 min from 100 micrograms to 2000 micrograms. 2. Plasma potassium (K), electrocardiographic (ECG) and haemodynamic (HR, SBP and DBP) responses were measured at each dose increment. 3. There were falls in K (as mean and 95% CI) in response to salbutamol (P less than 0.001): 3.70 mmol l-1 (3.46-3.95) to 3.20 mmol l-1 (2.91-3.49) MDI, 3.78 mmol l-1 (3.61-3.95) to 3.18 mmol l-1 (3.06-3.30) PSS. 4. Salbutamol produced marked ECG effects including T wave flattening (P less than 0.001): 0.46 mV (0.24-0.68) to 0.22 mV (0.07-0.37) MDI, 0.50 mV (0.23-0.77) to 0.24 mV (0.07-0.41) PSS; and Q-Tc interval prolongation (P less than 0.001): 0.382 s (0.372-0.392) to 0.409 s (0.397-0.421) MDI, 0.378 s (0.358-0.398) to 0.410 s (0.388-0.432) PSS. U waves occurred in five subjects with MDI and in four with PSS. S-T segment depression was present in two subjects with MDI and in three with PSS. These changes were not however associated with ventricular extrasystoles. There were also significant chronotropic effects (P less than 0.001): 63 beats min-1 (57-70) to 79 beats min-1 (69-89) MDI, 58 beats min-1 (53-63) to 75 beats min-1 (69-81) PSS. 5. Comparison of dose-response curves for MDI alone and with PSS showed no significant differences, for any of the variables measured.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
837

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Collier J. G., Dobbs R. J., Williams I. Salbutamol aerosol causes a tachycardia due to the inhaled rather than the swallowed fraction. Br J Clin Pharmacol. 1980 Mar;9(3):273–274. doi: 10.1111/j.1365-2125.1980.tb04837.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cushley M. J., Lewis R. A., Tattersfield A. E. Comparison of three techniques of inhalation on the airway response to terbutaline. Thorax. 1983 Dec;38(12):908–913. doi: 10.1136/thx.38.12.908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Eisenberg M. J. Magnesium deficiency and cardiac arrhythmias. N Y State J Med. 1986 Mar;86(3):133–136. [PubMed] [Google Scholar]
  4. Fuglsang G., Pedersen S. Comparison of Nebuhaler and nebulizer treatment of acute severe asthma in children. Eur J Respir Dis. 1986 Aug;69(2):109–113. [PubMed] [Google Scholar]
  5. Gleeson J. G., Price J. F. Nebuhaler technique. Br J Dis Chest. 1988 Apr;82(2):172–174. doi: 10.1016/0007-0971(88)90039-3. [DOI] [PubMed] [Google Scholar]
  6. Goldstein D. A., Tan Y. K., Soldin S. J. Pharmacokinetics and absolute bioavailability of salbutamol in healthy adult volunteers. Eur J Clin Pharmacol. 1987;32(6):631–634. doi: 10.1007/BF02456001. [DOI] [PubMed] [Google Scholar]
  7. Higgins R. M., Cookson W. O., Lane D. J., John S. M., McCarthy G. L., McCarthy S. T. Cardiac arrhythmias caused by nebulised beta-agonist therapy. Lancet. 1987 Oct 10;2(8563):863–864. doi: 10.1016/s0140-6736(87)91057-9. [DOI] [PubMed] [Google Scholar]
  8. Küng M., Croley S. W., Phillips B. A. Systemic cardiovascular and metabolic effects associated with the inhalation of an increased dose of albuterol. Influence of mouth rinsing and gargling. Chest. 1987 Mar;91(3):382–387. doi: 10.1378/chest.91.3.382. [DOI] [PubMed] [Google Scholar]
  9. Lindgren S. B., Larsson S. Inhalation of terbutaline sulphate through a conventional actuator or a pear-shaped tube: effects and side effects. Eur J Respir Dis. 1982 Nov;63(6):504–509. [PubMed] [Google Scholar]
  10. Lipworth B. J., Clark R. A., Dhillon D. P., Brown R. A., McDevitt D. G. Beta-adrenoceptor responses to high doses of inhaled salbutamol in patients with bronchial asthma. Br J Clin Pharmacol. 1988 Nov;26(5):527–533. doi: 10.1111/j.1365-2125.1988.tb05292.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Morgan D. J., Paull J. D., Richmond B. H., Wilson-Evered E., Ziccone S. P. Pharmacokinetics of intravenous and oral salbutamol and its sulphate conjugate. Br J Clin Pharmacol. 1986 Nov;22(5):587–593. doi: 10.1111/j.1365-2125.1986.tb02939.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Morris J., Milledge J. S., Moszoro H., Higgins A. The efficacy of drug delivery by a pear-shaped spacer and metered dose inhaler. Br J Dis Chest. 1984 Oct;78(4):383–387. [PubMed] [Google Scholar]
  13. Newman S. P., Millar A. B., Lennard-Jones T. R., Morén F., Clarke S. W. Improvement of pressurised aerosol deposition with Nebuhaler spacer device. Thorax. 1984 Dec;39(12):935–941. doi: 10.1136/thx.39.12.935. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Newman S. P., Pavia D., Clarke S. W. Simple instructions for using pressurized aerosol bronchodilators. J R Soc Med. 1980 Nov;73(11):776–779. doi: 10.1177/014107688007301105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Nordrehaug J. E., Johannessen K. A., von der Lippe G. Serum potassium concentration as a risk factor of ventricular arrhythmias early in acute myocardial infarction. Circulation. 1985 Apr;71(4):645–649. doi: 10.1161/01.cir.71.4.645. [DOI] [PubMed] [Google Scholar]
  16. Ohashi K., Turner P. Buccal absorption characteristics of some selective and non-selective beta-adrenoceptor agonists and antagonists [proceedings]. Br J Clin Pharmacol. 1980 Jan;9(1):120P–120P. doi: 10.1111/j.1365-2125.1980.tb04822.x. [DOI] [PubMed] [Google Scholar]
  17. Sears M. R., Rea H. H., Fenwick J., Gillies A. J., Holst P. E., O'Donnell T. V., Rothwell R. P. 75 deaths in asthmatics prescribed home nebulisers. Br Med J (Clin Res Ed) 1987 Feb 21;294(6570):477–480. doi: 10.1136/bmj.294.6570.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Stewart D. E., Ikram H., Espiner E. A., Nicholls M. G. Arrhythmogenic potential of diuretic induced hypokalaemia in patients with mild hypertension and ischaemic heart disease. Br Heart J. 1985 Sep;54(3):290–297. doi: 10.1136/hrt.54.3.290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Struthers A. D., Whitesmith R., Reid J. L. Prior thiazide diuretic treatment increases adrenaline-induced hypokalaemia. Lancet. 1983 Jun 18;1(8338):1358–1361. doi: 10.1016/s0140-6736(83)92140-2. [DOI] [PubMed] [Google Scholar]
  20. WEAVER W. F., BURCHELL H. B. Serum potassium and the electrocardiogram in hypokalemia. Circulation. 1960 Apr;21:505–521. doi: 10.1161/01.cir.21.4.505. [DOI] [PubMed] [Google Scholar]
  21. Walker S. R., Evans M. E., Richards A. J., Paterson J. W. The clinical pharmacology of oral and inhaled salbutamol. Clin Pharmacol Ther. 1972 Nov-Dec;13(6):861–867. doi: 10.1002/cpt1972136861. [DOI] [PubMed] [Google Scholar]
  22. Whyte K. F., Reid C., Addis G. J., Whitesmith R., Reid J. L. Salbutamol induced hypokalaemia: the effect of theophylline alone and in combination with adrenaline. Br J Clin Pharmacol. 1988 May;25(5):571–578. doi: 10.1111/j.1365-2125.1988.tb03347.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES